261 related articles for article (PubMed ID: 28774835)
21. Input of molecular analysis in medical management of primary brain tumor patients.
Idbaih A; Duran-Peña A; Bonnet C; Ducray F
Rev Neurol (Paris); 2015; 171(6-7):457-65. PubMed ID: 26026669
[TBL] [Abstract][Full Text] [Related]
22. A field guide for cancer diagnostics using cell-free DNA: From principles to practice and clinical applications.
Volckmar AL; Sültmann H; Riediger A; Fioretos T; Schirmacher P; Endris V; Stenzinger A; Dietz S
Genes Chromosomes Cancer; 2018 Mar; 57(3):123-139. PubMed ID: 29205637
[TBL] [Abstract][Full Text] [Related]
23. Glioblastoma: exosome and microRNA as novel diagnosis biomarkers.
Saadatpour L; Fadaee E; Fadaei S; Nassiri Mansour R; Mohammadi M; Mousavi SM; Goodarzi M; Verdi J; Mirzaei H
Cancer Gene Ther; 2016 Dec; 23(12):415-418. PubMed ID: 27834360
[TBL] [Abstract][Full Text] [Related]
24. Clinical prospects of long noncoding RNAs as novel biomarkers and therapeutic targets in prostate cancer.
Mouraviev V; Lee B; Patel V; Albala D; Johansen TE; Partin A; Ross A; Perera RJ
Prostate Cancer Prostatic Dis; 2016 Mar; 19(1):14-20. PubMed ID: 26503110
[TBL] [Abstract][Full Text] [Related]
25. Pancreatic cancer stem cell markers and exosomes - the incentive push.
Heiler S; Wang Z; Zöller M
World J Gastroenterol; 2016 Jul; 22(26):5971-6007. PubMed ID: 27468191
[TBL] [Abstract][Full Text] [Related]
26. The clinical relevance of circulating, exosomal miRNAs as biomarkers for cancer.
Schwarzenbach H
Expert Rev Mol Diagn; 2015; 15(9):1159-69. PubMed ID: 26202667
[TBL] [Abstract][Full Text] [Related]
27. Long intergenic non-protein-coding RNA 1567 (LINC01567) acts as a "sponge" against microRNA-93 in regulating the proliferation and tumorigenesis of human colon cancer stem cells.
Yu X; Mi L; Dong J; Zou J
BMC Cancer; 2017 Nov; 17(1):716. PubMed ID: 29110645
[TBL] [Abstract][Full Text] [Related]
28. Exosomal non-coding RNAs: a promising cancer biomarker.
Yang H; Fu H; Xu W; Zhang X
Clin Chem Lab Med; 2016 Dec; 54(12):1871-1879. PubMed ID: 27166723
[TBL] [Abstract][Full Text] [Related]
29. Decoding the usefulness of non-coding RNAs as breast cancer markers.
Amorim M; Salta S; Henrique R; Jerónimo C
J Transl Med; 2016 Sep; 14():265. PubMed ID: 27629831
[TBL] [Abstract][Full Text] [Related]
30. Circulating RNAs as new biomarkers for detecting pancreatic cancer.
Kishikawa T; Otsuka M; Ohno M; Yoshikawa T; Takata A; Koike K
World J Gastroenterol; 2015 Jul; 21(28):8527-40. PubMed ID: 26229396
[TBL] [Abstract][Full Text] [Related]
31. Clinical Relevance of Circulating, Cell-Free and Exosomal microRNAs in Plasma and Serum of Breast Cancer Patients.
Schwarzenbach H
Oncol Res Treat; 2017; 40(7-8):423-429. PubMed ID: 28683441
[TBL] [Abstract][Full Text] [Related]
32. [Classification of gliomas. Current progress and perspectives].
Capper D; Reifenberger G
Nervenarzt; 2015 Jun; 86(6):672, 674-6, 678-80, passim. PubMed ID: 25989737
[TBL] [Abstract][Full Text] [Related]
33. Diagnostic and prognostic markers in gliomas - an update.
Ma R; de Pennington N; Hofer M; Blesing C; Stacey R
Br J Neurosurg; 2013 Jun; 27(3):311-5. PubMed ID: 23278177
[TBL] [Abstract][Full Text] [Related]
34. Noncoding RNAs in Cancer Diagnosis.
Zeng MS
Adv Exp Med Biol; 2016; 927():391-427. PubMed ID: 27376744
[TBL] [Abstract][Full Text] [Related]
35. Expression of CD133 and other putative stem cell markers in uveal melanoma.
Thill M; Berna MJ; Grierson R; Reinhart I; Voelkel T; Piechaczek C; Galambos P; Jager MJ; Richard G; Lange C; Gehling UM
Melanoma Res; 2011 Oct; 21(5):405-16. PubMed ID: 21900792
[TBL] [Abstract][Full Text] [Related]
36. The Role of Cancer Stem Cells in Recurrent and Drug-Resistant Lung Cancer.
Suresh R; Ali S; Ahmad A; Philip PA; Sarkar FH
Adv Exp Med Biol; 2016; 890():57-74. PubMed ID: 26703799
[TBL] [Abstract][Full Text] [Related]
37. Current strategies in treatment of oligodendroglioma: evolution of molecular signatures of response.
Jaeckle KA; Ballman KV; Rao RD; Jenkins RB; Buckner JC
J Clin Oncol; 2006 Mar; 24(8):1246-52. PubMed ID: 16525179
[TBL] [Abstract][Full Text] [Related]
38. Integrating Genomics Into Neuro-Oncology Clinical Trials and Practice.
Galanis E; Nassiri F; Coy S; Nejad R; Zadeh G; Santagata S
Am Soc Clin Oncol Educ Book; 2018 May; 38():148-157. PubMed ID: 30231374
[TBL] [Abstract][Full Text] [Related]
39. LncRNA SOX2-OT is a novel prognostic biomarker for osteosarcoma patients and regulates osteosarcoma cells proliferation and motility through modulating SOX2.
Wang Z; Tan M; Chen G; Li Z; Lu X
IUBMB Life; 2017 Nov; 69(11):867-876. PubMed ID: 28960757
[TBL] [Abstract][Full Text] [Related]
40. Circulating microRNAs and long non-coding RNAs in gastric cancer diagnosis: An update and review.
Huang YK; Yu JC
World J Gastroenterol; 2015 Sep; 21(34):9863-86. PubMed ID: 26379393
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]